Life Science Compliance Update



New Leadership at the FDA Brings Change

Written by , Posted in Feature article

Robert N. Wilkey, Esq., Staff Writer for Life Science Compliance Update

On May 11, 2017, Dr. Scott Gottlieb was sworn in as the U.S. Food and Drug Administration’s latest Commissioner. Since that time, there has already been various regulatory changes and shifts, in terms of policy guidance, as well as a new focus toward easing the Agency’s rules and regulations pertaining to off-label uses. The article will explore those changes and the Agency continues to refine the “intended use” rules.


Topic tags:

Menu Title